Biohaven BHVN Return on equity

Return on equity at other companies

Eli LillyLLY

102.4%+15.7pp

Xenon PharmaceuticalsXENE

-43.6%+8.2pp

Rapport Therapeutics, Inc.RAPP

-40%+22.3pp

Vir Biotechnology, Inc.VIR

-26.1%-7.9pp

Monte Rosa Therapeutics, Inc.GLUE

-42.7%—

Avalo TherapeuticsAVTX

-36.3%—

FAQ

What is Biohaven's return on equity?

Biohaven (BHVN) reported return on equity of -333% in Q1 2026.

How has Biohaven's return on equity changed year-over-year?

Biohaven's return on equity decreased by 5.1% year-over-year, from -316.8% to -333%.

What is the long-term trend for Biohaven's return on equity?

Over 4 years (2021 to 2025), Biohaven's return on equity has grown at a -21.8% compound annual growth rate (CAGR), from -830.7% to -310.8%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.